朗逸品牌怎么样 申请店铺
四川升和药业股份有限公司，朗逸鱼腥草滴眼液，十大滴眼液品牌，集药品研究/开发生产和医药贸易为一体的高新技术医药企业
四川升和药业股份有限公司是集药品研究、开发、生产、医药投资为一体的企业。
公司下属三个制药分公司、一个省级企业技术中心。拥有小容量注射剂、大容量注射剂、片剂、硬胶囊剂、颗粒剂、滴眼剂、合剂、糖浆剂、口服溶液剂、原料药等20多条生产线；生产10个剂型、240个品种规格的药品及4个品种规格的保健食品。
产品体系拥有51项专利（含发明专利32项）、品种15个、中药保护品种6个；151个产品剂型中，95个入选国家医保目录，39个入选国家基本药物目录。主导产品为中药注射剂系列、眼科药物系列、专科固体制剂系列、抗肿瘤药物系列等，是国内中药注射剂领域核心企业之一。专业化销售和推广网络覆盖全国33个省（市）、500多家大中型医药经营企业和近万家各类终端医院；主导产品参麦注射液、香丹注射液、丹参注射液、鱼腥草滴眼液、肤痒颗粒、糖脉康颗粒等均位列国内市场占有率前5名。
公司的发展战略方向是现代中药制造以及围绕制药而延伸的医药流通、医疗服务产业链。未来5~10年，主要发展中药注射剂、抗肿瘤药物、及眼科和内分泌专科药物等产品，跻身中国主要中成药制药企业行列，成为专业化程度较高的集药品研发、药品生产、医药流通、医疗服务为一体的大型高科技医药产业集团公司。
Sichuan Shenghe Pharmaceutical Co., Ltd., Langyi Houttuynia eyedrop, one of the top ten eyedrop brands, is a high-tech pharmaceutical enterprise integrating pharmaceutical research, development, production and trade. Sichuan Shenghe Pharmaceutical Co., Ltd. is an enterprise integrating pharmaceutical research, development, production and investment. The company has three pharmaceutical branches and one provincial enterprise technology center. It has more than 20 production lines, including small volume injection, large volume injection, tablet, hard capsule, granule, eye drops, mixture, syrup, oral solution, API, etc.; it produces 10 dosage forms, 240 varieties and specifications of drugs and 4 varieties and specifications of health food. In the product system, there are 51 patents (including 32 invention patents), 15 varieties and 6 varieties protected by traditional Chinese medicine; of the 151 product formulations, 95 are listed in the national medical insurance catalog and 39 are listed in the national essential drug catalog. The leading products are traditional Chinese medicine injection series, ophthalmic medicine series, specialized solid preparation series, anti-tumor medicine series, etc. it is one of the core enterprises in the field of traditional Chinese medicine injection in China. The specialized sales and promotion network covers 33 provinces (cities), more than 500 large and medium-sized pharmaceutical business enterprises and nearly 10000 various terminal hospitals in China; the leading products Shenmai injection, Xiangdan injection, Danshen injection, Houttuynia eyedrops, Fuyang granules, Tangmaikang granules, etc. all rank in the top 5 in the domestic market share. The development strategic direction of the company is the modern Chinese medicine manufacturing and the pharmaceutical circulation and medical service industry chain extended around the pharmaceutical industry. In the next 5-10 years, we will mainly develop products such as traditional Chinese medicine injection, anti-tumor drugs, ophthalmic and endocrine specialty drugs, etc., and become one of the major Chinese patent medicine pharmaceutical enterprises in China. We will become a large high-tech pharmaceutical industry group company with high degree of specialization, integrating drug research and development, drug production, drug circulation and medical services.
本文链接： https://brand.waitui.com/402c34d5b.html 联系电话：02885142488
浙公网安备 33011802001999号
